Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4A | P47712 | 9/20 | 0.50 |
| ▸ | LTB4R | Q15722 | 3/20 | 0.47 |
| ▸ | CPT2 | P23786 | 1/20 | 0.47 |
| ▸ | CPT1A | P50416 | 1/20 | 0.47 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9490133 | 0.93 | NQO2 (0.43) | — | |
| SCHEMBL9488382 | 0.90 | CYSLTR2 (0.57) | PLA2G4ALTB4R | |
| SCHEMBL9490119 | 0.85 | MAPT (0.42) | CPT2CPT1ACPT1B | |
| SCHEMBL9488342 | 0.84 | PLA2G4A (0.51) | PLA2G4ALTB4RCPT2CPT1ACPT1B | |
| SCHEMBL9488822 | 0.84 | — | — | |
| SCHEMBL9490186 | 0.83 | PLA2G4A (0.41) | PLA2G4ALTB4R | |
| SCHEMBL9488905 | 0.83 | KMT2A (0.46) | PLA2G4ALTB4RCPT2CPT1ACPT1B | |
| SCHEMBL9488367 | 0.83 | CYSLTR2 (0.62) | — | |
| SCHEMBL9488613 | 0.83 | CYSLTR2 (0.49) | PLA2G4A | |
| SCHEMBL9757723 | 0.82 | NQO2 (0.42) | CPT2CPT1ACPT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0337766-B1 | HETERA-ALIPHATIC CARBOXAMIDES | ICI AMERICAS INC. (US) | 1993-03-10 | — | — | EP | disclosed |
| US-5041460-A | Antiallergens, antiinflammatory agents and leukotriene antagonists | ICI AMERICAS INC. (US) | 1991-08-20 | — | — | US | disclosed |
| EP-0337766-A1 | Hetera-aliphatic carboxamides | ICI AMERICAS INC. (US) | 1989-10-18 | — | — | EP | disclosed |